Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Wardelmann

Showing results (151-160 of 248) with videos related to

Pageof 25
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|April 15, 2014
TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entitiesChristian Koelsche, Marcus Renner, Wolfgang Hartmann, et al.
Pediatric Blood & Cancer|February 10, 2015
Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumorKornelius Kerl, Florian Oyen, Ivo Leuschner, et al.
International Journal of Molecular Sciences|August 12, 2023
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case ReportCarolin Krekeler, Klaus Wethmar, Jan-Henrik Mikesch, et al.
Plos One|February 17, 2018
Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatmentMichaela Angelika Ihle, Sebastian Huss, Wiebke Jeske, et al.
Oncotarget|February 22, 2018
T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-GChristian Spurny, Sareetha Kailayangiri, Bianca Altvater, et al.
Histopathology|September 8, 2022
Dataset for reporting of gastrointestinal stromal tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR)Jason L Hornick, Fleur Webster, Angelo Paolo Dei Tos, et al.
Oncotarget|January 7, 2016
NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factorCaroline Brand, Christoph Schliemann, Janine Ring, et al.
Oncogenesis|April 23, 2022
Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcomaRuth Berthold, Ilka Isfort, Cihan Erkut, et al.
Oncotarget|June 9, 2015
Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneityInga Grünewald, Claudia Vollbrecht, Jeannine Meinrath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2024
Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid LiposarcomaLorena Heinst, Kwang Seok Lee, Ruth Berthold, et al.
Pageof 25

Showing results (151-160 of 248) with videos related to

Sort By:
Pageof 25
Journal of Experimental & Clinical Cancer Research : CR|April 15, 2014
TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entitiesChristian Koelsche, Marcus Renner, Wolfgang Hartmann, et al.
Pediatric Blood & Cancer|February 10, 2015
Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumorKornelius Kerl, Florian Oyen, Ivo Leuschner, et al.
International Journal of Molecular Sciences|August 12, 2023
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case ReportCarolin Krekeler, Klaus Wethmar, Jan-Henrik Mikesch, et al.
Plos One|February 17, 2018
Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatmentMichaela Angelika Ihle, Sebastian Huss, Wiebke Jeske, et al.
Oncotarget|February 22, 2018
T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-GChristian Spurny, Sareetha Kailayangiri, Bianca Altvater, et al.
Histopathology|September 8, 2022
Dataset for reporting of gastrointestinal stromal tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR)Jason L Hornick, Fleur Webster, Angelo Paolo Dei Tos, et al.
Oncotarget|January 7, 2016
NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factorCaroline Brand, Christoph Schliemann, Janine Ring, et al.
Oncogenesis|April 23, 2022
Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcomaRuth Berthold, Ilka Isfort, Cihan Erkut, et al.
Oncotarget|June 9, 2015
Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneityInga Grünewald, Claudia Vollbrecht, Jeannine Meinrath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2024
Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid LiposarcomaLorena Heinst, Kwang Seok Lee, Ruth Berthold, et al.
Pageof 25